On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


The Reg A Conference 2023: Inspiration, Innovation, and Immersive Networking

Reg A sponsors and management, marketing consultants, structured finance investors, and deal advisors – all are invited to join The Reg A Conference June 30, 2023 at the Westchester Country Club in Rye, New York. This high-energy conference will bring private companies and finance experts together to promote discussion that can lead to deal making and to provide in-depth education regarding the increasingly popular Regulation A as a capital raising tool.

For executives and investors looking to raise capital at reduced cost – without leaping through the regulatory hoops of a traditional IPO – The Reg A Conference provides insight and education from thought leaders with years of experience at companies like Deloitte, Ernst & Young, Morgan Stanley, Woodruff Sawyer, and many more, along with unmatched opportunities to network with experts who get deals done.

Brought to you by DealFlow Events, The Reg A Conference offers unparalleled investment opportunities while attendees enjoy a comfortable environment for doing business, featuring indoor and outdoor event spaces in luxurious surroundings.

Expert speakers and panelists have deep experience in Regulation A offerings and will provide valuable insight into how they work: what’s involved, the rules, timelines, fees and case examples of actual results.

Connecting the Reg A community

Since its inception in 2015, Regulation A provides an indemnity from registration obligations for businesses that want to raise money through a public offering of securities. Regulation A has two tiers of public offerings. Each tier involves different reporting needs, as well as separate limits for the value of securities that can be sold in any given year. It is one of the most cost-effective ways of raising capital that small to medium-sized businesses can use to ramp up their growth and accelerate their success.

You don’t want to miss out.

To learn more, visit https://ibn.fm/n2LIh

From Our Blog

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors

March 18, 2024

With a fervent commitment to developing and commercializing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system, clinical-stage biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) continues to advance its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization. To boost […]

Rotate your device 90° to view site.